Therapeutic Advances in Rare Disease
Subject Categories
Subject Areas
Detailed Metrics
| Total Docs. (latest) | 22 |
| Total Docs. (3 years) | 65 |
| Total Refs. | 949 |
| Total Citations (3 years) | 137 |
| Citable Docs. (3 years) | 65 |
| Citations / Doc. (2 years) | 2.08 |
| Ref. / Doc. | 43.14 |
| % Female | 53.3% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Top 10 Most Cited Articles
Frequently Asked Questions
What is the impact factor of Therapeutic Advances in Rare Disease?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Therapeutic Advances in Rare Disease has an SJR of 0.503 and is ranked Q3.
What is the SJR and quartile of Therapeutic Advances in Rare Disease?
Therapeutic Advances in Rare Disease has an SJR (SCImago Journal Rank) of 0.503 and its best quartile is Q3.
What is the H-index of Therapeutic Advances in Rare Disease?
The H-index of Therapeutic Advances in Rare Disease is 11, meaning 11 of its articles have each been cited at least 11 times.
Is Therapeutic Advances in Rare Disease indexed in Scopus?
Yes. Therapeutic Advances in Rare Disease is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.